Square Pharma News Today

Square Pharmaceuticals Ltd recorded Tk 1,465 crore profit in the July-March period of the ongoing financial year, up around 9 percent year-on-year

It made Tk 24.83 crore in Oct-Dec of FY24, Tk 18.07 in the same period FY23

BSEC was on deeper monitoring over the week so that no group creates manipulative sell pressure in the market under peril due to the removal of the floor after nearly 18 months.

The Philippines has a fast-growing pharmaceutical market, with total sales of about $4.19 billion in 2022

Square Pharmaceuticals Limited has decided to invest $1 million in the Philippines for opening a company named Samson Pharma Inc. Samson Pharma will be incorporated in the Philippines.

It will invest $1 million in Samson Pharma Inc, Philippines

Square Pharmaceuticals PLC registered a 9 percent year-on-year growth in profit to Tk 600 crore in July-September this year.

Square Pharmaceuticals Ltd, the country’s biggest drug maker, has announced today its plan to invest Tk 400 crore for expansion. The funds would be used for BMRE (Balancing, Modernisation, Rehabilitation and Expansion), and the purchase of capital machinery and land for the future expansion of its business.

Square Pharmaceuticals PLC, the country’s biggest drug maker, has announced its plan to invest Tk 400 crore for expansion.

Square Pharma eyes for a share of the $2b generic drug market in East Africa